279 related articles for article (PubMed ID: 18037874)
1. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures.
Demicheli R; Retsky MW; Hrushesky WJ; Baum M
Nat Clin Pract Oncol; 2007 Dec; 4(12):699-710. PubMed ID: 18037874
[TBL] [Abstract][Full Text] [Related]
2. Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
Demicheli R
Semin Cancer Biol; 2001 Aug; 11(4):297-306. PubMed ID: 11513565
[TBL] [Abstract][Full Text] [Related]
3. Tumor dormancy: separating observations from experimental science.
Norton L
Nat Clin Pract Oncol; 2007 Dec; 4(12):671. PubMed ID: 18037872
[No Abstract] [Full Text] [Related]
4. Recurrence dynamics does not depend on the recurrence site.
Demicheli R; Biganzoli E; Boracchi P; Greco M; Retsky MW
Breast Cancer Res; 2008; 10(5):R83. PubMed ID: 18844974
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
[TBL] [Abstract][Full Text] [Related]
6. Does surgery modify growth kinetics of breast cancer micrometastases?
Demicheli R; Valagussa P; Bonadonna G
Br J Cancer; 2001 Aug; 85(4):490-2. PubMed ID: 11506484
[TBL] [Abstract][Full Text] [Related]
7. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
[TBL] [Abstract][Full Text] [Related]
8. Primary tumor resection improves the survival of younger patients with metastatic breast cancer.
Shien T; Kinoshita T; Shimizu C; Hojo T; Taira N; Doihara H; Akashi-Tanaka S
Oncol Rep; 2009 Mar; 21(3):827-32. PubMed ID: 19212646
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer dormancy can be maintained by small numbers of micrometastases.
Willis L; Alarcón T; Elia G; Jones JL; Wright NA; Tomlinson IP; Graham TA; Page KM
Cancer Res; 2010 Jun; 70(11):4310-7. PubMed ID: 20501854
[TBL] [Abstract][Full Text] [Related]
10. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site.
Cady B; Nathan NR; Michaelson JS; Golshan M; Smith BL
Ann Surg Oncol; 2008 Dec; 15(12):3384-95. PubMed ID: 18726129
[TBL] [Abstract][Full Text] [Related]
11. Reconstruction of the natural history of metastatic cancer and assessment of the effects of surgery: Gompertzian growth of the primary tumor.
Hanin L; Bunimovich-Mendrazitsky S
Math Biosci; 2014 Jan; 247():47-58. PubMed ID: 24211826
[TBL] [Abstract][Full Text] [Related]
12. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
13. Tumor dormancy: elevated expression of stanniocalcins in late relapsing breast cancer.
Joensuu K; Heikkilä P; Andersson LC
Cancer Lett; 2008 Jun; 265(1):76-83. PubMed ID: 18355956
[TBL] [Abstract][Full Text] [Related]
14. Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.
Khoshnoud MR; Fornander T; Johansson H; Rutqvist LE
Breast Cancer Res Treat; 2008 Jan; 107(1):71-8. PubMed ID: 18043896
[TBL] [Abstract][Full Text] [Related]
15. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
Tang SC
Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
[TBL] [Abstract][Full Text] [Related]
16. Biological therapy of breast cancer: recent clinical applications.
Baar J
Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
[TBL] [Abstract][Full Text] [Related]
17. Seeing the invisible: how mathematical models uncover tumor dormancy, reconstruct the natural history of cancer, and assess the effects of treatment.
Hanin L
Adv Exp Med Biol; 2013; 734():261-82. PubMed ID: 23143983
[TBL] [Abstract][Full Text] [Related]
18. Reducing early recurrence with adjuvant aromatase inhibitors: what is the evidence?
Dixon JM
Breast; 2008 Aug; 17(4):353-60. PubMed ID: 18490163
[TBL] [Abstract][Full Text] [Related]
19. [Primary breast angiosarcoma: two case reports].
Champeaux-Orange E; Bonneau C; Raharimanana B; Favre A; Ibrahim M; Breteau N
Cancer Radiother; 2009 Jun; 13(3):209-12. PubMed ID: 19410492
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.
Gomez-Fernandez C; Daneshbod Y; Nassiri M; Milikowski C; Alvarez C; Nadji M
Am J Clin Pathol; 2008 Dec; 130(6):879-82. PubMed ID: 19019763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
